Lori Rutman1,2, Eileen J Klein3,2, Julie C Brown3,2. 1. Department of Pediatrics, University of Washington, Seattle, Washington; and lori.rutman@seattlechildrens.org. 2. Division of Pediatric Emergency Medicine, Seattle Children's Hospital, Seattle, Washington. 3. Department of Pediatrics, University of Washington, Seattle, Washington; and.
Abstract
BACKGROUND AND OBJECTIVES: Despite widespread use of the rotavirus vaccine in the last decade, dehydrating illnesses impact almost 2 billion children worldwide annually. Evidence supports oral rehydration therapy as a first-line treatment of mild to moderate dehydration. Ondansetron has proven to be a safe and effective adjunct in children with vomiting. We implemented a clinical pathway in our pediatric emergency department (ED) in January 2005 to improve care for this common condition. Our objective in this study was to determine the long-term impact of the pathway for acute gastroenteritis (AGE) on the proportion of patients receiving intravenous (IV) fluids and ED length of stay (LOS) for discharged patients. METHODS: Cases were identified by using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. We used statistical process control to analyze process and outcome measures for 2 years before and 10 years after pathway implementation. RESULTS: We included 30 519 patients. We found special cause variation with a downward shift in patients receiving IV fluids after initiation of the pathway and later with addition of ondansetron to the pathway from 48% to 26%. Mean ED LOS for discharged patients with AGE decreased from 247 to 172 minutes. These improvements were sustained over time. CONCLUSIONS: Implementation of a clinical pathway emphasizing oral rehydration therapy and ondansetron for children with AGE led to decreased IV fluid use and LOS in a pediatric ED. Improvements were sustained over a 10-year period. Our results suggest that quality-improvement interventions for AGE can have long-term impacts on care delivery.
BACKGROUND AND OBJECTIVES: Despite widespread use of the rotavirus vaccine in the last decade, dehydrating illnesses impact almost 2 billion children worldwide annually. Evidence supports oral rehydration therapy as a first-line treatment of mild to moderate dehydration. Ondansetron has proven to be a safe and effective adjunct in children with vomiting. We implemented a clinical pathway in our pediatric emergency department (ED) in January 2005 to improve care for this common condition. Our objective in this study was to determine the long-term impact of the pathway for acute gastroenteritis (AGE) on the proportion of patients receiving intravenous (IV) fluids and ED length of stay (LOS) for discharged patients. METHODS: Cases were identified by using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. We used statistical process control to analyze process and outcome measures for 2 years before and 10 years after pathway implementation. RESULTS: We included 30 519 patients. We found special cause variation with a downward shift in patients receiving IV fluids after initiation of the pathway and later with addition of ondansetron to the pathway from 48% to 26%. Mean ED LOS for discharged patients with AGE decreased from 247 to 172 minutes. These improvements were sustained over time. CONCLUSIONS: Implementation of a clinical pathway emphasizing oral rehydration therapy and ondansetron for children with AGE led to decreased IV fluid use and LOS in a pediatric ED. Improvements were sustained over a 10-year period. Our results suggest that quality-improvement interventions for AGE can have long-term impacts on care delivery.
Authors: Corinne E Shubin; Lori E Rutman; A Luana Stanescu; Surabhi B Vora; George T Drugas; Michael G Leu; Rebekah A Burns Journal: Pediatr Qual Saf Date: 2020-05-28
Authors: Kristen H Shanahan; Michael C Monuteaux; Dalton Brunson; Sabrina E Guse; Mark E Alexander; John J Porter; Mark I Neuman; Andrew M Fine Journal: Pediatr Qual Saf Date: 2020-10-26
Authors: Elizabeth C Powell; Cindy G Roskind; David Schnadower; Cody S Olsen; T Charles Casper; Phillip I Tarr; Karen J O'Connell; Adam C Levine; Naveen Poonai; Suzanne Schuh; Alexander J Rogers; Seema R Bhatt; Serge Gouin; Prashant Mahajan; Cheryl Vance; Katrina Hurley; Ken J Farion; Robert E Sapien; Stephen B Freedman Journal: Ann Emerg Med Date: 2021-08-11 Impact factor: 6.762
Authors: Stephen B Freedman; Cindy G Roskind; Suzanne Schuh; John M VanBuren; Jesse G Norris; Phillip I Tarr; Katrina Hurley; Adam C Levine; Alexander Rogers; Seema Bhatt; Serge Gouin; Prashant Mahajan; Cheryl Vance; Elizabeth C Powell; Ken J Farion; Robert Sapien; Karen O'Connell; Naveen Poonai; David Schnadower Journal: Pediatrics Date: 2021-05-20 Impact factor: 9.703
Authors: Naveen Poonai; Elizabeth C Powell; David Schnadower; T Charles Casper; Cindy G Roskind; Cody S Olsen; Phillip I Tarr; Prashant Mahajan; Alexander J Rogers; Suzanne Schuh; Katrina F Hurley; Serge Gouin; Cheryl Vance; Ken J Farion; Robert E Sapien; Karen J O'Connell; Adam C Levine; Seema Bhatt; Stephen B Freedman Journal: JAMA Netw Open Date: 2021-04-01